Advertisement
Advertisement
U.S. Markets open in 5 hrs 2 mins
Advertisement
Advertisement
Advertisement
Advertisement

DBV Technologies S.A. (DBVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6500+0.0100 (+0.38%)
At close: 04:00PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space

    Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames Kenneth Truitt, M.D., with over 25 years of clinical and regulatory experience across biotechnology and large pharmaceutical companies, as Chief Medical Officer Reports inducement grant to Dr. Truitt under Nasdaq Listing Rule 5635(c)(4) WARREN, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (Nasdaq: AQST), a pharmaceutica

  • GlobeNewswire

    DBV Technologies Reports Second Quarter 2022 Financial Results

    Montrouge, France, August 1, 2022 DBV Technologies Reports Second Quarter 2022 Financial Results DBV closes Q2 with a cash balance of $248M following recent ATM and PIPE offeringsDBV continues to practice budget discipline measures; cash used in operating activities decreased more than 40% between the first half of 2021 and 2022The U.S. District Court, District of New Jersey, entered an order granting DBV’s Motion to Dismiss the Third Amended Class Action Complaint with prejudice DBV Technologie

  • GlobeNewswire

    Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

    AMF REGULATED INFORMATIONMontrouge, France, July 27, 2022 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with ODDO BHF. As of June 30, 2022, the following assets appeared on the liquidity account: 106,287 DBV Technologies shares;€ 430,854.35. Upon signing the liquidity contract in July

Advertisement
Advertisement